On Tuesday, Organon & Co (NYSE: OGN) was -3.34% drop from the session before settling in for the closing price of $10.19. A 52-week range for OGN has been $8.01 – $23.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -7.65%. When this article was written, the company’s average yearly earnings per share was at -6.05%. With a float of $258.99 million, this company’s outstanding shares have now reached $259.96 million.
The extent of productivity of a business whose workforce counts for 10000 workers is very important to gauge. In terms of profitability, gross margin is 57.18%, operating margin of 22.2%, and the pretax margin is 10.68%.
Organon & Co (OGN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Organon & Co stocks. The insider ownership of Organon & Co is 0.37%, while institutional ownership is 80.32%. The most recent insider transaction that took place on May 14 ’25, was worth 100,591. In this transaction Director of this company bought 12,469 shares at a rate of $8.07, taking the stock ownership to the 12,469 shares. Before that another transaction happened on May 07 ’25, when Company’s Chief Human Resources Officer bought 5,500 for $8.77, making the entire transaction worth $48,235. This insider now owns 62,974 shares in total.
Organon & Co (OGN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -6.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.19% during the next five years compared to -23.49% drop over the previous five years of trading.
Organon & Co (NYSE: OGN) Trading Performance Indicators
You can see what Organon & Co (OGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.41. Likewise, its price to free cash flow for the trailing twelve months is 3.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.89, a number that is poised to hit 0.94 in the next quarter and is forecasted to reach 4.08 in one year’s time.
Technical Analysis of Organon & Co (OGN)
The latest stats from [Organon & Co, OGN] show that its last 5-days average volume of 3.7 million was inferior to 4.64 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 73.99%. Additionally, its Average True Range was 0.49.
During the past 100 days, Organon & Co’s (OGN) raw stochastic average was set at 19.96%, which indicates a significant decrease from 66.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.05% in the past 14 days, which was lower than the 76.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.08, while its 200-day Moving Average is $14.88. Now, the first resistance to watch is $10.06. This is followed by the second major resistance level at $10.27. The third major resistance level sits at $10.42. If the price goes on to break the first support level at $9.69, it is likely to go to the next support level at $9.54. Assuming the price breaks the second support level, the third support level stands at $9.33.
Organon & Co (NYSE: OGN) Key Stats
There are 259,956K outstanding shares of the company, which has a market capitalization of 2.56 billion. As of now, sales total 6,403 M while income totals 864,000 K. Its latest quarter income was 1,513 M while its last quarter net income were 87,000 K.
